Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 585
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT05753735 | eXtended Antibiotic Prophylaxis for Intermediate- and High-risk Glands After Pancreatoduodenectomy to Reduce CR-POPF | ||
| NCT02842047 | The Mediating Effects of Decentering on Self-Management of Stress and End of Life Planning | ||
| NCT00361049 | Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell Transplant | ||
| NCT03827993 | Improving Sexual Health in Gynecologic Cancer Patients | ||
| NCT04248244 | Effects of Early Palliative Care Integration on Patients With Newly Diagnosed Multiple Myeloma | ||
| NCT03625765 | Integrated Imaging System for In Vivo Visualization of Free Flap Perfusion Using Indocyanine Dye | ||
| NCT03135444 | PSA TOOL for Prostate Cancer Screening Discussions | ||
| NCT01557881 | Positron Emission Tomography/Magnetic Resonance Imaging in Patients | ||
| NCT06824727 | Collection of Peripheral Blood From Patients With Hematologic Malignancies With Thrombocytopenia | ||
| NCT01118351 | Sunitinib Malate in Treating Patients With Recurrent Transitional Cell Bladder Cancer | ||
| NCT04639700 | Intervention for Caregivers of Patients Who Have Recently Undergone HSCT | ||
| NCT00110006 | Positron Emission Tomography Using Fludeoxyglucose F 18 in Predicting Response to Treatment in Patients Who Are Receiving Rituximab and Combination Chemotherapy for Newly Diagnosed Non-Hodgkin's Lymphoma | ||
| NCT00253448 | Stereotactic Radiosurgery and Radiation Therapy in Treating Patients With Glioblastoma Multiforme | ||
| NCT00023790 | Photodynamic Therapy in Treating Patients With Skin Cancer or Solid Tumors Metastatic to the Skin | ||
| NCT05590624 | Metabolic Impact of Prospective Controlled Mediterranean Type Diets on Prostate Cancer | ||
| NCT00281840 | Bevacizumab, Docetaxel, and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer | ||
| NCT00619515 | Stereotactic Radiation Therapy in Treating Patients With Prostate Cancer | ||
| NCT03272880 | Utilizing the Arts to Improve Health, Resilience, and Well-Being Among Cancer Patients and Their Caregivers | ||
| NCT02956291 | Multi-Parametric Quantitative MR Imaging in Evaluation of Brain Tumors | ||
| NCT02135562 | Protein-Sparing Modified Fast Intervention for Weight Loss in Obese Endometrial Cancer Survivors | ||
| NCT01843413 | Stereotactic Radiosurgery in Treating Patients With Large Brain Metastases | ||
| NCT06024603 | Individualized Treatments in Adults With Relapsed/Refractory Cancers | ||
| NCT03434769 | AntiCD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Non Hodgkin Lymphoma | ||
| NCT02128373 | A Computer-Based Intervention for Distance Caregivers of Parents With Advanced Cancer | ||
| NCT01165996 | Differentiation Therapy With Decitabine in Treating Patients With Myelodysplastic Syndrome | ||
| NCT03650803 | Role of Magnetic Resonance Fingerprinting and Quantitative MR Imaging in Breast Cancer | ||
| NCT00068523 | Ultraviolet-B Light Therapy and Allogeneic Stem Cell Transplantation in Treating Patients With Hematologic Malignancies | ||
| NCT00750009 | Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial | ||
| NCT00003567 | Gene Therapy and Chemotherapy in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma | ||
| NCT06926530 | Herbs & Supplements in Breast Cancer Usage, Impact, and Personalized Approaches for Diverse Populations | ||
| NCT02387840 | Feasibility and Clinically Application of Magnetic Resonance Fingerprinting | ||
| NCT00276549 | Gemcitabine and Docetaxel in Treating Patients With Metastatic Prostate Cancer | ||
| NCT04187833 | Nivolumab in Combination With Talazoparib in Melanoma and Mutations in BRCA or BRCA-ness Genes | ||
| NCT05028621 | Molecular Basis of Langerhans and Non-Langerhans Cell Histiocytic Neoplasms and Castleman Disease | ||
| NCT01839955 | Erlotinib Hydrochloride and Quinacrine Dihydrochloride in Stage IIIB-IV Non-Small Cell Lung Cancer | ||
| NCT07104630 | Pulmonary Rehabilitation in Advanced Lung Cancer Survivors | ||
| NCT00281853 | Nerve Changes in Patients Who Are Undergoing Chemotherapy or Biological Therapy for Cancer | ||
| NCT04176419 | Perioperative Analgesia on Postoperative Opioid Usage and Pain Control in H&N Cancer Surgery | ||
| NCT00352105 | Cisplatin, Fluorouracil, Iressa, and Radiation Therapy Patients With Locally Advanced Head and Neck Cancer | ||
| NCT01783522 | Glutamine in Preventing Peripheral Neuropathy in Patients With Multiple Myeloma Receiving Bortezomib | ||
| NCT00732745 | Vandetanib, Oxaliplatin, and Docetaxel in Advanced Cancer of the Esophagus or Gastroesophageal Junction | ||
| NCT05028101 | The Impact of Functional Medicine On Wound Healing From Delayed Autologous Breast Reconstruction | ||
| NCT07425054 | ctHPVDNA Response-Adapted Chemoradiation +/- Retifanlimab Treatment in Locally-Advanced Anal Cancer | ||
| NCT05333029 | Extracorporeal Photopheresis and Mesenchymal Stem Cell Infusion for GVHD | ||
| NCT00527293 | Partial Breast Radiation Therapy in Treating Women Undergoing Breast-Conserving Therapy for Early Stage Breast Cancer | ||
| NCT00047021 | Combination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia or Lymphoma | ||
| NCT02383433 | Regorafenib Plus Gemcitabine in Metastatic Pancreatic Cancer | ||
| NCT00853021 | Bevacizumab and Aldesleukin in Treating Patients With Metastatic Clear Cell Carcinoma of the Kidney | ||
| NCT02987998 | Neoadjuvant Chemoradiation Plus Pembrolizumab Followed By Consolidation Pembrolizumab in NSCLC | ||
| NCT06190249 | Efficacy & Safety for LN144 With Pembrolizumab With High Risk Stage IIIb-dResectable Melanoma |
